First PREMIER Bank »

Sab Biotherapeutics shares owned by First PREMIER Bank

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by First PREMIER Bank from 13F filings

Historical chart of First PREMIER Bank investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by First PREMIER Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by First PREMIER Bank

Quarter filed Position value Share count Share price at filing
2024-09-30 $52k 19k 2.68
2024-06-30 $60k 19k 3.10

More positions owned by First PREMIER Bank

Vanguard Total Stock Market Etf Total Stk Mkt (VTI)
Apple (AAPL)
Vanguard Value Etf Value Etf (VTV)
Invesco S&p 500 Downside Hedged Etf S&p500 Downsid (PHDG)
Vanguard Information Technology Etf Inf Tech Etf (VGT)
Microsoft Corporation (MSFT)
Procter & Gamble Company (PG)
Union Pacific Corporation (UNP)
Southern Company (SO)
Berkshire Hathaway Inc Del Cl B Cl B New (BRK.B)
Mastercard Inc Cl A Cl A (MA)
Duke Energy Corp Com New (DUK)
Invesco S&p 500 Low Volatility Etf S&p500 Low Vol (SPLV)
Johnson & Johnson (JNJ)
Vanguard Ftse All World Ex Us Etf Allwrld Ex Us (VEU)

View all positions for First PREMIER Bank

Top funds holding Sab Biotherapeutics

BVF
Marshall Wace
Sessa Capital IM
Vanguard Group
HB Wealth Management
Geode Capital Management
Millennium Management
Pathstone Holdings
First Manhattan
First PREMIER Bank
Institutional & Family Asset Management
BlackRock
Tower Research Capital
Morgan Stanley
Princeton Global Asset Management

View all funds holding Sab Biotherapeutics